Stents Market - By Product (Vascular Stents {Coronary, Peripheral, Neurovascular}, Non-vascular Stents), Material (Metal, Polymer), Type (Self Expandable, Balloon Expandable), End-use (Hospitals, ASCs) & Global Forecast 2024 – 2032

Stents Market Size

Stents Market size accounted for revenue of USD 9.4 billion in 2023, expanding at 4.7% CAGR to reach USD 14 billion by 2032. High growth of the market is attributable to increasing adoption of minimally invasive techniques, increasing cardiovascular surgeries, and a hectic lifestyle coupled with rising geriatric population will augment the market growth.
 

Rising adoption of unhealthy habits such as smoking and excessive alcohol usage, increasing consumption of junk food, and advancements in healthcare technology will propel industry growth in the future. Growing cardiovascular disorders and rising demand for minimally invasive procedures will foster the market growth. Moreover, novel developments in drug-eluting stent such as bifurcated stents as well as biodegradable materials, will boost the market value.
 

Stent is a plastic tube inserted into the lumen of an anatomic vessel or duct to keep the passageway open. These stents are often and widely used to treat narrowed coronary arteries that supply the heart with oxygen-rich blood. Moreover, stents are used in procedures or surgeries such as peripheral artery disease (stent replacement), deep vein thrombosis and coronary heart disease (stent placement) among others.
 

Stents Market Trends

Increasing number of coronary artery disease and peripheral vascular disorders globally will positively impact stent industry growth.
 

• Growing number of patient pool with chronic disease will drive the demand for percutaneous coronary intervention and peripheral vascular procedures. According to report published by Centers for Disease Control and Prevention (CDC) in 2020, coronary heart disease is the most common type of heart disease, killing 382,820 people. About 20.1 million adults aged 20 and older have coronary artery disease (CAD).
   
• As number of people suffering from coronary artery and peripheral vascular diseases is rising steadily, the demand for percutaneous coronary intervention and peripheral vascular procedures will increase. This will lead to increase in adoption rate of stents, thereby propelling business growth throughout the forecast timeline.
   
• Continuous rising cardiovascular disease incidences will have significant implication of healthcare resources, thereby accelerating industry growth in the region. Increasing number of chronic conditions such as cardiovascular disease and advancement in stents will drive industry growth in the future.
   

Stents Market Analysis

Based on product, the market is segmented into vascular stents and non-vascular stents. The vascular stent segment is anticipated to reach USD 13 billion by 2032.
 

• Vascular stents are used in opening narrowed blood vessels and clearing blockages. The growing burden of cardiovascular diseases will fuel the product demand. Furthermore, the surge in demand for surgeries among the population is expected to boost the segment expansion.
   
• Vascular stents are used to prevent the stenosis of blood vessels and restore blood flow. Increasing rates of cardiovascular disease due to sedentary lifestyle and smoking will boost the demand for vascular stents.
• Moreover, high growth rate is attributable to growing burden of coronary artery disease and technological advancements for development of advanced vascular stents.
   

The stents market by material is categorized into metal and polymer. The metal segment dominates the market with the revenue of around USD 7.5 billion in 2023.
 

• Metal is the material of choice for stents due to advantages such as lower rates of stent fracture, flexibility and biocompatibility. Integration of metallic stents with biodegradable polymers to overcome the limitations of conventional will be another factor instrumental in propelling the segment growth.
   
• Furthermore, the durable nature of metal stents and the low rate of stent fracture will drive the market growth.
   

Based on type, the stents market is segmented into self-expandable and balloon expandable. The balloon expandable stent segment held leading revenue share in 2023 and is anticipated to reach USD 8.8 billion by 2032.
 

• Balloon expandable stents support high radial outward force due to their rigidity. Furthermore, they offer long-term integrity and higher elasticity, thereby positively impacting the segmental expansion over the forecast period.
   
• Moreover, high growth rate is due to better radial stiffness, high adoption rate and approvals for balloon expandable stents from regulatory bodies.  
   

The stents market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment held majority revenue share and was valued at around USD 6.9 billion in 2023.
 

• The demand for stents in hospitals continues to surge, driven by the rising prevalence of cardiovascular diseases and advancements in interventional cardiology procedures. As hospitals strive to meet the growing needs of patients requiring stent implantation, there's a heightened emphasis on stocking a diverse range of stent types, including drug-eluting, bare metal stents, and bioresorbable stents, to cater to individual patient requirements.
   
• Additionally, the shift towards minimally invasive techniques has bolstered the demand for stents, as they offer effective solutions with reduced recovery times and improved patient outcomes.
   
• Availability of skilled surgeons and better post-operative care in hospitals will drive the segment expansion. Furthermore, supply agreements between hospitals and manufacturers will drive the industry expansion.
   

North America stents market accounted for USD 2.1 billion revenue in 2023 and is predicted to witness substantial market growth.
 

• The demand for stents in North America is on the rise due as, the region has a high prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, which necessitate the use of stents for treatment. Additionally, there is a growing aging population in the region, leading to an increased incidence of cardiovascular conditions and subsequent demand for stents.
   
• Moreover, technological advancements in stent design and materials have contributed to the increasing demand, as newer stents offer improved efficacy and safety profiles.
   
• Furthermore, favorable reimbursement policies for stenting procedures in the region have encouraged healthcare providers to offer these interventions more frequently, further boosting the demand for stents.
   

Stents Market Share

Prominent players operating in the stents industry include Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, among others. These industry players are noted to have undertaken certain strategic initiatives such as product launches and approvals assisting them to sustain the market competition. Ongoing advancements aim to improve stent design, durability, and biocompatibility while reducing risks of complications such as restenosis or thrombosis. Collaboration between medical professionals and device manufacturers drives innovation in this critical area of cardiovascular care.
 

Stents Market Companies

Some of the eminent market participants operating in the stents industry include:

• Abbott Laboratories
• B. Braun Melsungen AG
• Biosensors International Group
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Becton, Dickinson and Company
• Elixir Medical Corporation
• Medtronic Plc
• Meril Life Science
• MicroPort Scientific Corporation
• Stryker Corporation
• Terumo Corporation
• Veryan Medical Limited
• W.L Gore & Associates
   

Stents Industry News:

• In May 2022, Medtronic received the U.S. FDA approval for its Onyx frontier drug eluting stent indicated for coronary artery disease in patients with plaque buildup inside the coronary arteries. This launch enabled the company to expand its product portfolio and increase its customer base thus driving the revenue growth.
   
• In September 2021, Microport announced a strategic acquisition of its subsidiary Shanghai Microport Medical Co., Ltd with Fujian Kerui Pharmaceutical Co., Ltd. This acquisition enhanced sustainability of company’s supply chain management system to accelerate the availability of Microport drug eluting stents all over the world.  
   

Stents market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in (USD Million) and volume (Units) from 2018 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Vascular stents
  • Coronary stents
    • Bare metal stents
    • Drug eluting stents
    • Bioresorbable stents
  • Peripheral stents
    • Iliac
    • Femoral-Popliteal
    • Renal
    • Carotid
  • Neurovascular stents
• Non-vascular stents

Market, By Material

• Metal
• Polymer

Market, By Type

• Self-expandable
• Balloon expandable

Market, By End-use

• Hospitals
• Ambulatory surgical centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Singapore
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa